Statements Author contributions All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication
Griffiths KK, Wang A, Wang L, Tracey M, Kleiner G, Quinzii CM, et al
Most of the research in this area has focused specifically on alcohol addiction, and researchers have known for a while now from animal studies that GLP-1 receptor agonists decrease alcohol intake, reduce the motivation to consume alcohol, and even prevent relapse drinking by potentially lowering alcohol-induced reward
If such treatment is not tolerated or is contraindicated, a GLP-1 RA with proven cardiovascular outcomes benefit could be considered to reduce MACE and should be continued until kidney replacement therapy is indicated
Get Started Today If youre ready to explore the benefits of Semaglutide or Tirzepatide weight loss injections in Wichita, our team at Elevate Wellness is here to help